Meyka Pro banner
Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation (NASDAQ: IART) AI-Powered Stock Analysis

See how Integra LifeSciences Holdings Corporation scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.

IARTNASDAQ
HealthcareMedical - Devices
$18.24
$0.86(4.95%)
U.S. Market opens in 2h 18m

Integra LifeSciences Holdings Corporation (NASDAQ: IART) AI-Powered Stock Analysis

See how Integra LifeSciences Holdings Corporation scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full Disclaimer

Integra LifeSciences Holdings Corporation (NASDAQ: IART) Stock Overall Grade

Integra LifeSciences Holdings Corporation's grade for its NASDAQ listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

Z

Grade Breakdown by Metric

See how each financial and market factor contributes to Integra LifeSciences Holdings Corporation's overall NASDAQ stock rating.

Forecast

B

Score

63/100

Financial Growth

C+

Score

55/100

Fundamental Growth

C+

Score

58/100

Key Ratios

C+

Score

50/100

Sector Comparison

B+

Score

75/100

Industry Comparison

C+

Score

50/100

S&P 500 Benchmark

A+

Score

98/100

Analyst Consensus

C+

Score

50/100

Integra LifeSciences Holdings Corporation (NASDAQ: IART) AI-Powered Stock Analysis

On the NASDAQ, IART demonstrates Good performance with an overall Forecast Score of 63/100 (B), reflecting high confidence in its potential. Financial Growth (55/100, C+) and Fundamental Growth (58/100, C+) highlight its stability, while Key Ratios (50/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), the NASDAQ-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.

(NASDAQ: IART) Component Analysis Explained

Understand the key factors behind each Integra LifeSciences Holdings Corporation (NASDAQ: IART) stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions